Jiro Kato

3.1k total citations
64 papers, 2.4k citations indexed

About

Jiro Kato is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jiro Kato has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Jiro Kato's work include PARP inhibition in cancer therapy (22 papers), Toxin Mechanisms and Immunotoxins (17 papers) and Calcium signaling and nucleotide metabolism (10 papers). Jiro Kato is often cited by papers focused on PARP inhibition in cancer therapy (22 papers), Toxin Mechanisms and Immunotoxins (17 papers) and Calcium signaling and nucleotide metabolism (10 papers). Jiro Kato collaborates with scholars based in United States, Japan and Taiwan. Jiro Kato's co-authors include Junichi Ueda, Joel Moss, Masato Mashimo, Shunya Oka, Hideki Tanzawa, Atsuko Tanaka, Shiroh Isono, Takashi Nishino, Daisuke Araki and Toshihide Watanabe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jiro Kato

62 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Kato United States 20 949 851 607 578 381 64 2.4k
Jan S. Ryerse United States 24 1.0k 1.1× 327 0.4× 244 0.4× 237 0.4× 41 0.1× 50 2.4k
Li Fang China 32 1.9k 2.0× 234 0.3× 118 0.2× 408 0.7× 36 0.1× 140 3.4k
Xiaohong Li United States 31 1.5k 1.6× 232 0.3× 480 0.8× 761 1.3× 38 0.1× 89 2.9k
Koji Uetsuka Japan 26 687 0.7× 203 0.2× 447 0.7× 472 0.8× 18 0.0× 113 2.2k
Jean‐Louis Connat France 19 678 0.7× 284 0.3× 109 0.2× 428 0.7× 31 0.1× 62 1.8k
Edward F. C. Blommaart Netherlands 11 1.9k 2.0× 109 0.1× 206 0.3× 473 0.8× 340 0.9× 14 3.5k
Haiyang Chen China 26 928 1.0× 131 0.2× 267 0.4× 228 0.4× 37 0.1× 85 1.8k
Sabrina Di Bartolomeo Italy 27 1.4k 1.5× 283 0.3× 162 0.3× 277 0.5× 241 0.6× 61 3.1k
Jian Zhong United States 29 1.6k 1.7× 220 0.3× 88 0.1× 688 1.2× 30 0.1× 60 3.3k
O‐Yu Kwon South Korea 21 821 0.9× 277 0.3× 101 0.2× 352 0.6× 14 0.0× 117 1.9k

Countries citing papers authored by Jiro Kato

Since Specialization
Citations

This map shows the geographic impact of Jiro Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Kato more than expected).

Fields of papers citing papers by Jiro Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Kato. The network helps show where Jiro Kato may publish in the future.

Co-authorship network of co-authors of Jiro Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Kato. A scholar is included among the top collaborators of Jiro Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Kato. Jiro Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Acharya, Dhiraj, Maximilian Hirschenberger, Matthew A. Zurenski, et al.. (2025). TRIM23 mediates cGAS-induced autophagy in anti-HSV defense. Nature Communications. 16(1). 4418–4418. 6 indexed citations
2.
Mashimo, Masato, Xiangning Bu, Kazumasa Aoyama, et al.. (2019). PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells. JCI Insight. 4(4). 39 indexed citations
3.
Kato, Jiro, Youn Wook Chung, Junhui Sun, et al.. (2018). Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair. JCI Insight. 3(22). 19 indexed citations
4.
Bu, Xiangning, Jiro Kato, & Joel Moss. (2018). Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways. Biochemical Pharmacology. 167. 44–49. 18 indexed citations
5.
Leutert, Mario, Kathrin Nowak, Jiro Kato, et al.. (2017). Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase. Nature Communications. 8(1). 2055–2055. 96 indexed citations
6.
El‐Chemaly, Souheil, Gustavo Pacheco–Rodriguez, Daniela Malide, et al.. (2014). Nuclear Localization of Vascular Endothelial Growth Factor-D and Regulation of c-Myc–Dependent Transcripts in Human Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 51(1). 34–42. 14 indexed citations
7.
Niere, Marc, Masato Mashimo, Christian Dölle, et al.. (2012). ADP-ribosylhydrolase 3 (ARH3), Not Poly(ADP-ribose) Glycohydrolase (PARG) Isoforms, Is Responsible for Degradation of Mitochondrial Matrix-associated Poly(ADP-ribose). Journal of Biological Chemistry. 287(20). 16088–16102. 90 indexed citations
8.
Kato, Jiro, Jianfeng Zhu, Chengyu Liu, et al.. (2011). ADP-Ribosylarginine Hydrolase Regulates Cell Proliferation and Tumorigenesis. Cancer Research. 71(15). 5327–5335. 40 indexed citations
9.
Nakashima, Eitaro, Atsuko Watarai, Yoji Hamada, et al.. (2010). Association of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients. Journal of Diabetes Investigation. 1(4). 154–158. 13 indexed citations
10.
Kato, Jiro, et al.. (2005). Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene. Gene. 351. 83–95. 2 indexed citations
11.
Oka, Shunya, Jiro Kato, & Joel Moss. (2005). Identification and Characterization of a Mammalian 39-kDa Poly(ADP-ribose) Glycohydrolase. Journal of Biological Chemistry. 281(2). 705–713. 231 indexed citations
12.
Iwado, Akimasa, Masaki Mifune, Jiro Kato, et al.. (2000). Catalytic Activity of Anion-Exchange Resins Modified with Metal-Porphine in Oxidative Reactions of Phenols.. Chemical and Pharmaceutical Bulletin. 48(11). 1831–1832. 9 indexed citations
13.
Kato, Jiro, Shiroh Isono, Atsuko Tanaka, et al.. (2000). Dose-Dependent Effects of Mandibular Advancement on Pharyngeal Mechanics and Nocturnal Oxygenation in Patients With Sleep-Disordered Breathing. CHEST Journal. 117(4). 1065–1072. 210 indexed citations
14.
Kobayashi, Hiroyuki, Jiro Kato, Hiroshi Morioka, Jon D. Stewart, & Eiko Ohtsuka. (1999). Tryptophan H33 plays an important role in pyrimidine (6–4) pyrimidone photoproduct binding by a high-affinity antibody. Protein Engineering Design and Selection. 12(10). 879–884. 11 indexed citations
15.
Kato, Jiro, et al.. (1989). A CLINICAL STUDY AND THE DIAGNOSIS IN MAGNETIC RESONANCE IMAGING OF RENAL SCARRING. The Japanese Journal of Urology. 80(4). 532–539. 1 indexed citations
16.
Ueda, Junichi & Jiro Kato. (1980). Isolation and Identification of a Senescence-promoting Substance from Wormwood (Artemisia absinthium L.). PLANT PHYSIOLOGY. 66(2). 246–249. 344 indexed citations
17.
Kato, Jiro, et al.. (1966). Physiological activities of helminthosporol in comparison with those of gibberellin and auxin. Planta. 68(4). 353–359. 17 indexed citations
18.
Kato, Jiro, et al.. (1962). On the By-products of Hydroformylation Reaction of Acrylonitrile. The Journal of the Society of Chemical Industry Japan. 65(2). 184–187.
19.
Kato, Jiro, et al.. (1962). The Behavior of Propargyl Alcohol as an Inhibitor for the Dissolution of Mild Steel into Acid Media. The Journal of the Society of Chemical Industry Japan. 65(4). 640–641. 1 indexed citations
20.
Fujii, Takashi, et al.. (1960). he Behavior of Cobalt Hydrocarbonyl under Various Conditions of the Oxo Reaction. The Journal of the Society of Chemical Industry Japan. 63(6). 960–963.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan S. Ryerse Breakdown of academic impact, for papers by Li Fang Breakdown of academic impact, for papers by Xiaohong Li Breakdown of academic impact, for papers by Koji Uetsuka Breakdown of academic impact, for papers by Jean‐Louis Connat Breakdown of academic impact, for papers by Edward F. C. Blommaart Breakdown of academic impact, for papers by Haiyang Chen Breakdown of academic impact, for papers by Sabrina Di Bartolomeo Breakdown of academic impact, for papers by Jian Zhong Breakdown of academic impact, for papers by O‐Yu Kwon
Rankless by CCL
2026